Angus Wu has years of experience in business development, strategic partnership, global market access, marketing and commercialization in the space of precision cancer medicine, and in vitro diagnostics. Prior to Anbogen, he was the Associate VP of ACT Genomics, who led partnering and M&A activities with Canon Medical, oncology-focused biopharmas and diagnostic company that brought in substantial revenue from technology licensing, and regional partnership in Asia.